| # | Holder | Shares | % of Shares Out | Change | Filing Date |
|---|---|---|---|---|---|
| 1 |
Horton Capital Management LLC
|
9.775m | 21.18% | -876.758k | Feb 24 2023 |
| 2 |
First Light Asset Management, LLC
|
6.338m | 13.73% | +64.309k | Dec 31 2022 |
| 3 |
Archon Capital Management LLC
|
2.970m | 6.43% | — | Dec 31 2022 |
| 4 |
Frommer (Kathy S)
|
1.735m | 3.76% | +5.221k | Mar 31 2022 |
| 5 |
The Vanguard Group, Inc.
|
1.347m | 2.92% | +678.000 | Dec 31 2022 |
|
1
Horton Capital Management LLC
|
21.18%
9.775m
|
|
2
First Light Asset Management, LLC
|
13.73%
6.338m
|
|
3
Archon Capital Management LLC
|
6.43%
2.970m
|
|
4
Frommer (Kathy S)
|
3.76%
1.735m
|
|
5
The Vanguard Group, Inc.
|
2.92%
1.347m
|
| The largest shareholders show who really holds influence: big institutional owners shape a stock's liquidity, and building or cutting positions can move the price. | |
| The 5 largest shareholders together hold 48.03% of Repro-Med Systems, Inc., with Horton Capital Management LLC the biggest at 21.18%, followed by First Light Asset Management, LLC (13.73%) and Archon Capital Management LLC (6.43%). |
| Date | Insider & Role | Type | Price | Quantity | Volume |
|---|---|---|---|---|---|
| Oct 08 2026 |
John Mitchell
CEO
|
Purchases
|
$182.45 | + 15,000 | $2,736,750 |
| Oct 05 2026 |
Sarah Chen
CFO
|
Sales
|
$179.80 | - 8,500 | $1,528,300 |
| Oct 01 2026 |
Robert Williams
COO
|
Purchases
|
$175.20 | + 12,000 | $2,102,400 |
| Sep 26 2026 |
Emily Rodriguez
Director
|
Sales
|
$181.30 | - 5,200 | $942,760 |
| Sep 20 2026 |
Michael Thompson
SVP Operations
|
Purchases
|
$170.50 | + 20,000 | $3,410,000 |
| Sep 13 2026 |
Lisa Park
General Counsel
|
Sales
|
$177.90 | - 6,800 | $1,209,720 |
| No transactions found for this filter. | |||||
|
John Mitchell
PURCHASES
|
Oct 08 2026
$182.45
|
|
Sarah Chen
SALES
|
Oct 05 2026
$179.80
|
|
Robert Williams
PURCHASES
|
Oct 01 2026
$175.20
|
|
Emily Rodriguez
SALES
|
Sep 26 2026
$181.30
|
|
Michael Thompson
PURCHASES
|
Sep 20 2026
$170.50
|
|
Lisa Park
SALES
|
Sep 13 2026
$177.90
|
| No transactions found for this filter. | |
| Insider transactions show you what executives, directors and major shareholders do with their own stock: people who know the company from the inside. Buys are the most telling signal, because insiders invest their own money. Sells are harder to read, since they can also be driven by taxes, diversification or expiring option programs. |
| Short interest shows what share of a stock's freely tradable shares (float) is currently sold short, meaning held by investors betting on falling prices. A high or rising level can be read two ways: it reflects the skepticism of many market participants, but also carries upside potential. Because if the stock rises, short sellers have to buy back, which can push the price up even further. This effect is called a short squeeze. | |
| The short interest in Repro-Med Systems, Inc. has held steady at around 2.6% of the float over the past 12 months. Short sellers' positioning has barely changed in this period. |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


